The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 115:740-741, February 1959
doi: 10.1176/appi.ajp.115.8.740
© 1959 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by PENNINGTON, V. M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by PENNINGTON, V. M.

CLINICAL RESULTS OF TRIFLUPROMAZINE (VESPRIN) IN 132 PSYCHOTIC PATIENTS

VERONICA M. PENNINGTON M.D.

Vesprin (oral or parenteral) is an effective phrenotropic agent in many acute and chronic psychotic cases. It is capable of restoring patients in all classifications of schizophrenia as well as in the manic-depressive, manic type groups.

Because side effects are benign and dosage-controlled, Vesprin is a safe medicament in the hands of careful and experienced workers.







Get information about faster international access.

Privacy Policy

Copyright © 1959 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org